Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S3 from Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers
  1. Home
  2. Publications
  3. Supplementary Table S3 from Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers

Supplementary Table S3 from Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers

Authors:
  • PKPatricia J. Keller
    Patricia J. Keller
  • EAElizabeth J. Adams
    Elizabeth J. Adams
  • RWRentian Wu
    Rentian Wu
  • ACAlexandre Côté
    Alexandre Côté
  • SAShilpi Arora
    Shilpi Arora
  • NCNico Cantone
    Nico Cantone
  • RMRosana Meyer
    Rosana Meyer
  • JMJennifer A. Mertz
    Jennifer A. Mertz
  • VGVictor Gehling
    Victor Gehling
  • JCJike Cui
    Jike Cui
  • JSJacob I. Stuckey
    Jacob I. Stuckey
  • AKAvinash Khanna
    Avinash Khanna

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/0008-5472.32705683
Abstract
Table listing experimentally determined compound binding affinities for EZH2 and EZH1 containing PRC2 protein complexes
Keywords
  • CLINICAL-STAGE RESEARCH
  • EPIGENETICS
  • HISTONE MODIFICATION
  • GENITOURINARY CANCERS
  • BLADDER CANCER
  • GYNECOLOGICAL CANCERS
  • ENDOMETRIAL CANCER
  • OVARIAN CANCER
  • SMALL MOLECULE AGENTS
  • EPIGENETIC-TARGETED AGENTS
  • TRANSLATIONAL RESEARCH
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.